Tasly Pharmaceutical Group Co Ltd (600535) – Strategy, SWOT and Corporate Finance Report
- Pages: 36
- Published: May 2023
- Report Code: MLPH139197FSA
Tasly Pharmaceutical Group Co Ltd (600535) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Tasly Pharmaceutical Group Co Ltd (Tasly) manufactures and distributes chemical medicine, biological medicine, healthcare products, traditional Chinese medicine (TCM), functional food and other products. The company's product line includes herbal medicine, chemical medicine, prescription drugs, pharmaceutical substances, health product, active pharmaceutical ingredients (APIs), herbal extract, tea, cosmetics, daily hygiene product series, and medical equipment. It markets products in the domestic market through its own sales force and through distributors and subsidiaries in Malaysia, Indonesia, Vietnam, South Korea, Pakistan, Thailand, Istanbul, Botswana, South Africa, Ghana, Kenya, Zambia, Nigeria, Russia, the Netherlands, and the US. Tasly is headquartered in Tianjin, China.
Scope
• Detailed information on Tasly Pharmaceutical Group Co Ltd required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Tasly Pharmaceutical Group Co Ltd in the form of a SWOT analysis
• An in-depth view of the business model of Tasly Pharmaceutical Group Co Ltd including a breakdown and examination of key business segments
• News about Tasly Pharmaceutical Group Co Ltd, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Tasly Pharmaceutical Group Co Ltd and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Tasly Pharmaceutical Group Co Ltd as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Tasly Pharmaceutical Group Co Ltds business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Shandong Buchang Pharmaceutical Co Ltd
China Medical System Holdings Ltd
Tianyin Pharmaceutical Co Inc
HPGC Renmintongtai Pharmaceutical Corp
China National Accord Medicines Corporation Ltd
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
AccuBioTech Co Ltd
Sinochem Hebei Corp
Shanghai Pharmaceuticals Holding Co Ltd
Jinyao Pharmaceutical Co Ltd
Chongqing Taiji Industry (Group) Co Ltd
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
Sinopharm Group Co Ltd
Tianjin Tianyao Pharmaceuticals Co Ltd
Sinochem Hebei Corp
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
Tianyin Pharmaceutical Co Inc
HPGC Renmintongtai Pharmaceutical Corp
China National Accord Medicines Corporation Ltd
Sinopharm Group Co Ltd
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
AccuBioTech Co Ltd
Shandong Buchang Pharmaceutical Co Ltd
China Medical System Holdings Ltd
Shanghai Pharmaceuticals Holding Co Ltd
Chongqing Taiji Industry (Group) Co Ltd
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.